Results for tag: "Onpattro"

The Onpattro market is a subset of the Central Nervous System (CNS) drugs market. It is composed of drugs used to treat neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. These drugs are typically administered orally, intravenously, or intramuscularly. They are designed to target specific areas of the brain and spinal cord to reduce symptoms and improve quality of life. Onpattro drugs are typically expensive and require a prescription from a doctor. They are often used in combination with other treatments such as physical therapy, occupational therapy, and lifestyle changes. Some of the major companies in the Onpattro market include Pfizer, Merck, Novartis, and Sanofi. These companies are involved in the research, development, and marketing of Onpattro drugs. Other companies such as AbbVie, Biogen, and Teva Pharmaceuticals also have a presence in the Onpattro market. Show Less Read more